StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie net Periodic OPEB Cost ($M) ($M)

Form 10-Q / 10-K Post-Employment Benefits Note

QuarterlyAnnual
Latest, Q2 2026
13
Period ended Jun 30, 2026
Change on a year earlier
-7.1%
14 in Q2 2025
History
36 quarters
Since Q3 2017
Sources
31
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Periodic OPEB Cost ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202613-7.1%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 202615+7.1%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 202515-6.2%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 202515-6.2%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 202514-17.6%Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 202514-12.5%Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 202416+23.1%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 202416+33.3%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 202417+21.4%Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 202416+45.5%Form 10-Q (filed 2025-05-09) ↗
Q4 2023Dec 31, 202313-13.3%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 202312-25.0%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jun 30, 202314-12.5%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 202311-26.7%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 2022150.0%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 202216+6.7%Form 10-Q (filed 2023-11-06) ↗

Cite this data

StockData. (2026). AbbVie Net Periodic OPEB Cost ($M) ($M), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/db_opeb_net_cost

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.